Skip to main content
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.75
+0.47 (3.54%)
At close: Apr 28, 2026, 4:00 PM EDT
13.71
-0.04 (-0.29%)
After-hours: Apr 28, 2026, 4:04 PM EDT

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.62M in the quarter ending December 31, 2025, with 9.76% growth. This brings the company's revenue in the last twelve months to $66.98M, up 0.58% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$66.98M
Revenue Growth
+0.58%
P/S Ratio
5.94
Revenue / Employee
$558,167
Employees
120
Market Cap
397.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
Vanda Pharmaceuticals 216.11M
Niagen Bioscience 129.42M
Autolus Therapeutics 75.39M
X4 Pharmaceuticals 35.11M
Lineage Cell Therapeutics 14.56M
Silence Therapeutics 559.00K
YD Bio 510.36K
Revenue Rankings

ENTA News

More News